Similar articles

• Radioiodine and the immune system.

  DeGroot LJ. DeGroot LJ. Thyroid. 1997 Apr;7(2):259-64. doi: 10.1089/thy.1997.7.259. Thyroid. 1997. PMID: 9133697 Review.
• Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism.

  Chang TC, Chang CC, Chen FW, Liaw KY. Chang TC, et al. Taiwan Yi Xue Hui Za Zhi. 1986 Dec;85(12):1177-82. Taiwan Yi Xue Hui Za Zhi. 1986. PMID: 2880926 No abstract available.
• (131)I and thyroid-associated ophthalmopathy.

  Rasmussen AK, Nygaard B, Feldt-Rasmussen U. Rasmussen AK, et al. Eur J Endocrinol. 2000 Aug;143(2):155-60. doi: 10.1530/eje.0.1430155. Eur J Endocrinol. 2000. PMID: 10913933 Review.
• Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.

  Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Chiovato L, et al. Clin Endocrinol (Oxf). 1994 Jun;40(6):803-6. doi: 10.1111/j.1365-2265.1994.tb02516.x. Clin Endocrinol (Oxf). 1994. PMID: 8033373
• Effect of radioiodine therapy on the presence of autoantibodies against human thyroid and eye muscle fractions.

  Molnár I, Balázs C. Molnár I, et al. J Endocrinol Invest. 2000 Jan;23(1):63-4. doi: 10.1007/BF03343678. J Endocrinol Invest. 2000. PMID: 10698054 No abstract available.